Cardiovascular therapeutics
-
Multicenter Study Clinical Trial
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Inhaled treprostinil is a prostacyclin analog approved for the treatment of pulmonary arterial hypertension (PAH) that may provide a more convenient treatment option for patients receiving inhaled iloprost while maintaining the clinical benefit of inhaled prostacyclin therapy. ⋯ Pulmonary arterial hypertension patients can be safely transitioned from inhaled iloprost to inhaled treprostinil while maintaining clinical status.